Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition
===================================================================================================================================================

* Meagan-Helen Henderson Berg
* Sonia Victoria del Rincón
* Wilson H Miller